Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

17.140
+0.2101.24%
Volume:2.79M
Turnover:47.74M
Market Cap:45.47B
PE:11.54
High:17.260
Open:16.780
Low:16.780
Close:16.930
52wk High:28.232
52wk Low:14.505
Shares:2.65B
HK Float Shares:535.00M
Volume Ratio:0.49
T/O Rate:0.52%
Dividend:0.45
Dividend Rate:2.63%
EPS(LYR):1.485
ROE:6.95%
ROA:1.40%
PB:0.80
PE(LYR):11.54
PS:0.91

Loading ...

Sinopharm Group Stock Climbs 2.1% in Hong Kong

Dow Jones
·
Jul 16

Fosun Pharma Receives NMPA Clearance to Begin Phase I Trial of siRNA Candidate FXR0906 for Hypertriglyceridemia

Bulletin Express
·
Jul 15

Shanghai Fosun Pharma - Unit Got Approval from Nmpa China for Clinical Trial of Fxr0906 for Treatment of Hypertriglyceridemia

THOMSON REUTERS
·
Jul 15

Fosun Pharma's Subsidiary Receives Approval for FXR0906 Injection Clinical Trial

Stock News
·
Jul 15

Sinopharm Group Stock Rises 2.6% in Hong Kong

Dow Jones
·
Jul 15

Sinopharm Group Stock Slides 3.0% in Hong Kong

Dow Jones
·
Jul 09

Sinopharm Group Stock Advances 3.0% in Hong Kong

Dow Jones
·
Jul 06

Sinopharm Group Stock Climbs 1.9% in Hong Kong

Dow Jones
·
Jul 03

Sinopharm Group Stock Rises 3.3% in Hong Kong

Dow Jones
·
Jul 02

Shanghai Junshi Biosciences HK Shares Hit 4-week Peak on Fosun's Licensing Deal

Reuters
·
Jul 02

Fosun Pharma to Offload Partnership Fund Stake for 1 Million Yuan; Shares Down 4%

MT Newswires Live
·
Jun 30

Fosun Pharma's Unit Gets Registration Nod for Spasm, Pain Drug in China

MT Newswires Live
·
Jun 29

Shanghai Fosun Pharma - Drug Registration Application for Shaoyao Gancao Tang Granules Approved by Nmpa

THOMSON REUTERS
·
Jun 29

Fosun Pharma's Subsidiary Gains Approval for Shaoyao Gancao Tang Granules

Stock News
·
Jun 29

Sinopharm Group Stock Rises 2.3% in Hong Kong

Dow Jones
·
Jun 29

Fosun Pharma's Vaccine Unit Submits Hong Kong Listing Application

MT Newswires Live
·
Jun 29

Fosun Pharma Seeks Approval to List Subsidiary Fosun Antigen on Hong Kong Main Board

Stock News
·
Jun 26

Shanghai Fosun Pharma - Co was Informed That Fosun Adgenvax Submitted Listing Application for Listing of Its H Shares on HKEX Main Board

THOMSON REUTERS
·
Jun 26

Sinopharm Group Stock Advances 1.1% in Hong Kong

Dow Jones
·
Jun 24

Sinopharm Group Stock Falls 2.7% in Hong Kong

Dow Jones
·
Jun 18